Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 1 - 42
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 47 - 48
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 45 - 46
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 43 - 44
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: the PANORAMIC trial
Png ME. et al, (2024), British Journal of General Practice, 74, e570 - e579
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek A. et al, (2022), The Lancet Respiratory Medicine, 10, 840 - 850
Corrigendum: Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT
Hopewell S. et al, (2022), Health technology assessment (Winchester, England), 25, 159 - 160
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Abhishek A. et al, (2022), BMJ Open, 12
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Hinks TSC. et al, (2021), The Lancet Respiratory Medicine, 9, 1130 - 1140
Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: The grasp factorial RCT
Hopewell S. et al, (2021), Health Technology Assessment, 25, VII - 90
A RANDOMISED CLINICAL TRIAL OF AZITHROMYCIN VERSUS STANDARD CARE IN AMBULATORY COVID-19-THE ATOMIC2 TRIAL
Hinks TSC. et al, (2021), THORAX, 76, A35 - A35
Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: Statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial
Marian IR. et al, (2020), Trials, 21
Effects of anacetrapib in patients with atherosclerotic vascular disease
Bowman L. et al, (2017), New England Journal of Medicine, 377, 1217 - 1227